著書論文等- 井樋 慶一 -
表示方法: 表示形式: 表示順:
[]:著書 []:論文 []:総説・解説記事
件数:162件
[2016]
1.[] Distribution of corticotropin-releasing factor neurons in the mouse brain: a study using corticotropin-releasing factor-modified yellow fluorescent protein knock-in mouse..[Brain Structure and Function,(2016),1-28]Kono J, Konno K, Talukder AH, Fuse T, Abe M, Uchida K, Horio S, Sakimura K, Watanabe M, Itoi K
10.1007/s00429-016-1303-0
2.[] 下垂体疾患診療マニュアル 改訂版.[診断と治療社,(2016)]井樋慶一
3.[] A novel GABA-mediated corticotropin-releasing hormone secretory mechanism in the median eminence..[Science Advances,2(e1501723),(2016),1-15]Kakizawa K, Watanabe M, Mutoh H, Okawa Y, Yamashita M, Yanagawa Y, Itoi K, Suda T, Oki Y, Fukuda A
[2015]
4.[] ヒト扁桃体研究ハンドブック.[西村初手kん,(2015)]泉井亮,井樋慶一,中澤潤,岡田元宏
ISBN978-4-89013-455-7
5.[] ストレス防御に関与する神経内分泌系と自律神経系の構造と機能.[科学評論社 内分泌・糖尿病・代謝内科,40(5), (2015), 412-420]井樋慶一
6.[] Exploring the Regulatory Mechanism of Stress Responses in the Paraventricular Nucleus of the Hypothalamus: Backgrounds and Future Perspectives of Corticotropin-Releasing Factor-Modified Yellow Fluorescent Protein-Knock-In Mouse..[Interdisciplinary Information Sciences,21,(2015),213-224]Itoi K.
7.[] Transcriptional Regulation of Vasopressin Gene: Update in 2015..[Interdisciplinary Information Sciences,21,(2015),267-272]Iwasaki Y, Itoi K
[2014]
8.[] Catecholamine Research in the 21st Century.[Academic Press, New York,(2014)]Itoi K, Sugimoto N, Uchida K, Fuse T, Das G, Ohara S, Kobayashi K
9.[] Visualization of corticotropin-releasing factor neurons by fluorescent proteins in the mouse brain and characterization of labeled neurons in the paraventricular nucleus of the hypothalamus..[Endocrinology,155,(2014),4054-4060]Itoi K, Talukder AF, Fuse T, Kaneko T, Ozawa R, Sato T, Sugaya T, Uchida K, Yamazaki M, Abe M, Natsume R, Sakimura K
10.[] Amelioration of improper differentiation of somatostatin-positive interneurons by triiodothyronine in a growth-retarded hypothyroid mouse strain..[Neuroscience Letters,559,(2014),111-116]Uchida K, Taguchi Y, Sato C, Miyazaki H, Kobayashi K, Kobayashi T, Itoi K
11.[] Stimulation of corticotropin-releasing factor gene expression by FosB in rat hypothalamic 4B cells..[Peptides,51,(2014),59-64]Kageyama K, Itoi K, Iwasaki Y, Niioka K, Watanuki Y, Yamagata S, Nakada Y, Das G, Suda T, Daimon M
[2013]
12.[] Selective ablation of dopamine beta-hydroxylase neurons in the brain by immunotoxin-mediated neuronal targeting: new insights into brain catecholaminergic circuitry and catecholamine-related diseases..[Advances in Pharmacology,68,(2013),155-166]Itoi K, Ohara S, Kobayashi K
13.[] CRFニューロン調節メカニズム解明を目指した遺伝子改変動物の作成と応用..[ACTH Related Peptides,24,(2013),42-43]井樋慶一
14.[] Oxytocin receptor in the hypothalamus is sufficient to rescue normal thermoregulatory function in male oxytocin receptor knockout mice..[Endocrinology,154,(2013),4305-4315]Kasahara Y, Sato K, Takayanagi Y, Mizukami H, Ozawa K, Hidema S, So KH, Kawada T, Inoue N, Ikeda I, Roh SG, Itoi K, Nishimori K
[2012]
15.[] 下垂体疾患診断マニュアル.[診断と治療社,(2012)]井樋慶一
16.[] 気になる脳部位 視床下部室傍核..[分子精神医学,12,(2012),37-41]井樋慶一
17.[] イムノトキシンニューロンターゲティング法を用いた脳内ストレス応答系の検討..[ACTH-Relate Peptides,23,(2012),34-36]井樋慶一
18.[] 気になる脳部位 視床下部室傍核.[先端医学社 分子精神医学, (2012)]井樋慶一
[2011]
19.[] バソプレシンおよびオキシトシンの中枢作用と創薬ターゲットとしてのバソプレシン受容体、オキシトシン受容体の意義.[メディカルビュー社 Fluid Management Renaissance, (2011)]井樋慶一、布施俊光、内田克哉
20.[] Targeting of Locus Ceruleus Noradrenergic Neurons Expressing Human Interleukin-2 Receptor alpha-Subunit in Transgenic Mice by a Recombinant Immunotoxin anti-Tac(Fv)-PE38: A Study for Exploring Noradrenergic Influence upon Anxiety-Like and Depression-Like Behaviors.[JOURNAL OF NEUROSCIENCE,31(16),(2011),6132-6139]Itoi K, Sugimoto N, Suzuki S, Sawada K, Das G, Uchida K, Fuse T, Ohara S, Kobayashi K
10.1523/JNEUROSCI.5188-10.2011
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000289769400027&DestApp=WOS
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University